Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen L Lessnick

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
Annual Review of Pathology|September 28, 2011
Molecular pathogenesis of Ewing sarcoma: new therapeutic and transcriptional targetsStephen L Lessnick, Marc Ladanyi
Cancer Genetics|August 30, 2011
Promiscuous partnerships in Ewing's sarcomaSavita Sankar, Stephen L Lessnick
Cell Cycle (Georgetown, Tex.)|October 18, 2008
Microsatellites are EWS/FLI response elements: genomic "junk" is EWS/FLI's treasureKunal Gangwal, Stephen L Lessnick
Current Treatment Options in Oncology|October 26, 2005
The potential for molecular therapeutic targets in Ewing's sarcomaNancy R McAllister, Stephen L Lessnick
Current Opinion in Genetics & Development|February 3, 2009
Pediatric malignancies: update on sarcomas and leukemia development in childrenBenjamin S Braun, Stephen L Lessnick
F1000Research|September 17, 2016
Recent advances in targeted therapy for Ewing sarcomaKathleen I Pishas, Stephen L Lessnick
Cell Cycle (Georgetown, Tex.)|September 14, 2006
Identification of target genes in their native cellular context: an analysis of EWS/FLI in Ewing's sarcomaLeah A Owen, Stephen L Lessnick
Oncotarget|December 19, 2018
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutationKathleen I Pishas, Stephen L Lessnick
Cell Cycle (Georgetown, Tex.)|February 8, 2008
A transcriptional profiling meta-analysis reveals a core EWS-FLI gene expression signatureJeffrey D Hancock, Stephen L Lessnick
Sarcoma|July 21, 2011
The molecular basis of sarcomaStephen L Lessnick, Heinrich Kovar, Peter Houghton
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
Annual Review of Pathology|September 28, 2011
Molecular pathogenesis of Ewing sarcoma: new therapeutic and transcriptional targetsStephen L Lessnick, Marc Ladanyi
Cancer Genetics|August 30, 2011
Promiscuous partnerships in Ewing's sarcomaSavita Sankar, Stephen L Lessnick
Cell Cycle (Georgetown, Tex.)|October 18, 2008
Microsatellites are EWS/FLI response elements: genomic "junk" is EWS/FLI's treasureKunal Gangwal, Stephen L Lessnick
Current Treatment Options in Oncology|October 26, 2005
The potential for molecular therapeutic targets in Ewing's sarcomaNancy R McAllister, Stephen L Lessnick
Current Opinion in Genetics & Development|February 3, 2009
Pediatric malignancies: update on sarcomas and leukemia development in childrenBenjamin S Braun, Stephen L Lessnick
F1000Research|September 17, 2016
Recent advances in targeted therapy for Ewing sarcomaKathleen I Pishas, Stephen L Lessnick
Cell Cycle (Georgetown, Tex.)|September 14, 2006
Identification of target genes in their native cellular context: an analysis of EWS/FLI in Ewing's sarcomaLeah A Owen, Stephen L Lessnick
Oncotarget|December 19, 2018
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutationKathleen I Pishas, Stephen L Lessnick
Cell Cycle (Georgetown, Tex.)|February 8, 2008
A transcriptional profiling meta-analysis reveals a core EWS-FLI gene expression signatureJeffrey D Hancock, Stephen L Lessnick
Sarcoma|July 21, 2011
The molecular basis of sarcomaStephen L Lessnick, Heinrich Kovar, Peter Houghton
Pageof 10